Eucure (Beijing) Biopharma Co., Ltd

Industry

  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on Eucure (Beijing) Biopharma Co., Ltd

Scrip

Riding US Approval, Junshi, Coherus Swing For PD-1 Combo Therapy Partnerships

 
• By Dexter Jie Yan

Having successfully landed their anti-PD-1 Loqtorzi (toripalimab) in the US, Shanghai Junshi Biosciences Co., Ltd. and Coherus BioSciences, Inc. are set to jump-start a partnership bonanza for pot

Scrip

Asia Deal Watch: Astellas Invests In Taysha, Gets Rights To Two AAV Gene Therapies

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. $50m Taysha Investment Gives Astel

Scrip

Asia Deal Watch: I-Mab Partners With Sinopharm As It Readies First Regulatory Filing

 
• By Joseph Haas, Dexter Jie Yan, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. I-Mab Readies For Commercial Activity V